Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCRL | Q16602 | 20/20 | 0.66 |
| ▸ | RAMP1 | O60894 | 1/20 | 0.52 |
| ▸ | CALCA | P06881 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13036893 | 1.00 | CALCRL (0.66) | CALCRLRAMP1CALCA | |
| SCHEMBL2766016 | 0.86 | CALCRL (0.74) | CALCRLRAMP1CALCA | |
| SCHEMBL13050743 | 0.85 | CALCRL (0.73) | CALCRLRAMP1CALCA | |
| SCHEMBL13051210 | 0.85 | CALCRL (0.73) | CALCRLRAMP1CALCA | |
| SCHEMBL13050740 | 0.85 | CALCRL (0.73) | CALCRLRAMP1CALCA | |
| SCHEMBL13345743 | 0.85 | CALCRL (0.61) | CALCRLRAMP1CALCA | |
| SCHEMBL13025489 | 0.85 | CALCRL (0.61) | CALCRLRAMP1CALCA | |
| SCHEMBL13025486 | 0.85 | CALCRL (0.61) | CALCRLRAMP1CALCA | |
| SCHEMBL13025498 | 0.85 | CALCRL (0.61) | CALCRLRAMP1CALCA | |
| SCHEMBL13036911 | 0.84 | CALCRL (0.60) | CALCRLRAMP1CALCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7829699-B2 | Process for the preparation of CGRP antagonist | MERCK SHARP & DOHME CORP. (US) | 2010-11-09 | — | — | US | disclosed |
| US-7718796-B2 | Process for the preparation of caprolactam CGRP antagonist | MERCK SHARP & DOHME CORP. (US) | 2010-05-18 | — | — | US | disclosed |
| US-20090281306-A1 | efficient synthesis for the preparation of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1 -carboxamide; salt formation of potassium salt forms; treating migraine and cluster headache | MERCK SHARP & DOHME CORP. | 2009-11-12 | — | — | US | disclosed |
| US-20090124799-A1 | Process for the preparation of Caprolactam Cgrp Antagonist | MERCK SHARP & DOHME CORP. | 2009-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124799-A1 | Process for the preparation of Caprolactam Cgrp Antagonist | CALCRL, CALCR, CALCA | CALCRL 1/4885RAMP1 14/4885CALCA 3/4885 |
| US-20090281306-A1 | efficient synthesis for the preparation of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1 -carboxamide; salt formation of potassium salt forms; treating migraine and cluster headache | KCNJ2, KCNN2, KCNN1 | CALCRL 200/4885RAMP1 877/4885CALCA 181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.